Form 4: Amprius CTO Executes Option, Sells Shares
Insider Transaction Report
Amprius Technologies' Chief Technology Officer, Stefan Constantin Ionel, exercised stock options and subsequently sold a portion of his common stock holdings under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Chief Technology Officer Stefan Constantin Ionel of Amprius Technologies, Inc. executed transactions on December 11, 2025.
- Ionel exercised stock options to acquire 125,000 shares of common stock at an exercise price of $0.05 per share.
- Concurrently, Ionel sold 198,255 shares of common stock at an average price of $10.5086 per share, with individual transactions ranging from $10.14 to $11.49.
- These transactions were conducted under a Rule 10b5-1 trading plan established on September 11, 2025.
- Following these transactions, Ionel beneficially owns 748,696 shares of common stock, which includes 585,697 restricted stock units (RSUs).
- Ionel also holds 310,962 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the execution under a pre-arranged Rule 10b5-1 plan mitigates concerns about opportunistic selling based on undisclosed information. It represents a planned liquidity event for the executive.
Positives
- The exercise of stock options indicates the executive is realizing value from previously granted equity incentives.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned liquidity event rather than a reaction to recent company news.
Negatives
- The sale of 198,255 shares by a key executive could be perceived negatively by some investors, potentially signaling a lack of confidence, although mitigated by the 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transactions were conducted under a Rule 10b5-1 trading plan, which is a common corporate governance mechanism allowing insiders to sell shares without concerns of insider trading, provided the plan is established when the insider is not in possession of material non-public information. | 09/11/2025 | Enhances transparency and reduces potential for insider trading allegations by pre-scheduling trades. |
Stakeholder Impact
- Shareholders may interpret the insider sale differently; some may view it as a routine liquidity event, while others might perceive it as a negative signal, despite the 10b5-1 plan. The transparency provided by the Form 4 allows for informed decision-making.
Key Dates
| Date | Description |
|---|---|
| 09/14/2022 | Date stock options became exercisable. |
| 09/11/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 12/11/2025 | Date of stock option exercise and common stock sale transactions. |
| 12/15/2025 | Date the Form 4 was signed. |
| 03/15/2027 | Expiration date of the stock options. |
Keywords
Amprius Technologies, AMPX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Chief Technology Officer, Stefan Constantin Ionel, Rule 10b5-1 Plan, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.